Eligibility criteria
Condition
Asthma
Sex
Females and Males
Age
18-70 years
Inclusion criteria
Show details
- Moderate to severe persistent asthma for at least 1 year
- Demonstrated reversibility of at least 9% and (FEV1) 50% to 80% predicted
- Subjects must be on a high-dose inhaled corticosteroid (ICS)
Exclusion criteria
Show details
- Previous treatment with etanercept
- Current use of cigarettes
- Significant concurrent medical conditions at the time of screening